11
Views
2
CrossRef citations to date
0
Altmetric
Review

Gene therapy for cardiovascular diseases

&
Pages 1385-1393 | Published online: 25 Feb 2005

Bibliography

  • GROSSMAN M, RADER DJ, MULLER DWM et al: A pilot of ex vivo gene therapy for homozygous familial hypercholesterolaemia. Nature Med. (1995)1:1148–1154.
  • •The first study using ex vivo gene therapy to treat familial hypercholesterolaemia.
  • MESRI EA, FEDEROFF HJ, BROWNLEE M: Expression of vascular endothelial growth factor from a defective herpes simplex virus Type 1 amplicon vector induces angiogenesis. Circ. Res. (1995) 76:161–167.
  • LOSORDO DW, VALE PR, SYMES JF et al: Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation (1998) 98:2800–2804.
  • ••The first human trial for therapeutic angiogenesis.
  • ESAKOFF DD, MAYSKY M, LORODO DW et al.: Intraop-erative multiplane transesophageal echocardi-ography for guiding direct intramyocardial gene transfer of vascular endothelial growth factor in patients with refractory angina pectoris. Hum. Gene. Ther. (1999) 10:2307–2314.
  • BARR E, CARROLL J, KALYNYCH AM: Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus. Gene Ther. (1994) 1 :31–58 .
  • VALE PR, LOSORDO DW, TKEBUCHAVA T, CHEN D, MILLIKEN CE, ISNER JM: Catheter-based myocardial gene transfer utilizing nonfluoroscopic electro-maechanical left ventricular mapping. j Am. Coll Cardiol. (1999) 34:246–254.
  • VARENNE O, GERARD RD, SINNAEVE P, GILLIJNS H, COLLEN D, JANSSENS S: Percutaneous adenoviral gene transfer into porcine coronary arteries: is catheter- gene delivery adapted to coronary circulation. Hum. Gene Ther. (1999) 10:1105–1115.
  • FROMES Y, SALMON A, WANG X et al.: Gene delivery to the myocardium by intrapericardial injection. Gene Ther. (1999) 6:683–688.
  • MACRIS MP, IGO SR: Minimally invasive access of the normal pericardium: initial clinical experience with a novel device. Clin. Cardiol. (1999) 22:1–36–1–39.
  • GUZMAN RJ, HIRSCHOWITZ EA, BRODY SL, CRYSTAL RG, EPSTEIN SE, FINKEL T: In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. Proc. Natl. Acad. Sci. USA (1994) 91:10732–10736.
  • CHANG MW, BARR E, SELTZER J et al. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science (1995) 267:518–522.
  • CHANG MW, BARR E, LU MM, BARTON K, LEIDEN JM: Adenovirus-mediated overexpression of the cyclin/ cyclin-dependent kinase inhibitor, p21, inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty. J. Clin. Invest. (1995)96:2260–2268.
  • SMITH RC, BRANELLEC D, GORSKI DH, GUO K, PERLMAN H, DEDIEU JF: p21CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodo-main gene. Genes Dev. (1997) 11:1674–1689.
  • VAN BELLE E, TIO FO, CHEN D et al: Passivation of metallic stents after arterial gene transfer of phVEGF165 inhibits thrombus formation and intimal thickening. j Am. Coll. Cardiol. (1997) 29:1371–1379.
  • BAFFOUR R, BERMAN J, GARB JL, RHEE SW, KAUFMAN J, FRIEDMANN P: Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor. j Vasa Sing. (1992) 16:181–191.
  • TAKESHITA S, ZHENG LP, BROGI E et al: Therapeutic angiogenesis: a single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J. Clin. Invest. (1994) 93:662–670.
  • ISNER JM, PIECZEK A, SCHAINFELD R et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet (1996) 348:370–374.
  • •The first study to use VEGF in humans to treat ischaemia.
  • PRENTICE H, KLONER RA, LI Y, NEWMAN L, KEDES L: Ischemic/reperfused myocardium can express recombinant protein following direct DNA or retroviral injection. J. Mo/. Cell. Cardiol. (1996) 94:11–332–11–336.
  • MURRY CE., KAY MA, BARTOSEKT, HAUSCHKA SD, SCHWARTZ SM: Muscle differentiation during repair of myocardial necrosis in rats via gene transfer with MyoD. j Clin. Inv. (1998) 98:2209–2217.
  • LEOR J, PATTERSON M, QUINONES MJ, KEDES LH, KLONER RA: Transplantation of fetal myocardial tissue into the infarcted myocardium of rat; a potential method for repair of infarcted myocardium. Circula-tion (1996) 94:11–332–11–336.
  • LEFKOWITZ RJ, GLOWER DD, KOCH WJ: Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary132-adrenergic receptor gene delivery. J. Clin. Invest. (1999) 104:21–29.
  • •The first study to use gene therapy to treat heart failure.
  • CABLE DG, CACCITOLO JA, PEARSON PJ et al: New approaches to prevention and treatment of radial artery graft vasospasm. Circulation (1998) 98:11–15–11–22.
  • GEROGE SJ, JOHNSON JL, ANGELINI GD, NEWBY AC, BAKER AH: Adenovirus-mediated gene transfer of the human TIMP-1 gene inhibits smooth muscle cell migration and neointimal formation in human saphenous vein. Hum. Gene Ther. (1998) 9:867–877.
  • YONEMITSU Y, KANEDA Y, TANAKA S, NAKASHIMA Y, KOMORI K, SUGIMACHI K, SUEISHI K: Transfer of wild-type p53 gene effectively inhibits vascular smooth muscle cell proliferation in vitro and in vivo. Circ. Res. (1998) 82(2):147–156.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.